Centessa Pharmaceuticals plc ADR (CNTA) Performance and Fundamentals Dashboard tells a completely different story

With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.0 million shares. The 52-week range on CNTA shows that it touched its highest point at $19.09 and its lowest point at $7.75 during that stretch. It currently has a 1-year price target of $31.56. Beta for the stock currently stands at 1.53.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CNTA was down-trending over the past week, with a drop of -9.63%, but this was up by 4.59% over a month. Three-month performance dropped to -35.37% while six-month performance fell -23.12%. The stock gained 27.20% in the past year, while it has lost -26.57% so far this year. A look at the trailing 12-month EPS for CNTA yields -1.99 with Next year EPS estimates of -1.54. For the next quarter, that number is -0.33. This implies an EPS growth rate of 30.49% for this year and -7.68% for next year. EPS is expected to grow by 6.65% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -210.04%.

Float and Shares Shorts:

At present, 132.63 million CNTA shares are outstanding with a float of 84.29 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CNTA since 6 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$1.43021 being high and -$1.783 being low. For CNTA, this leads to a yearly average estimate of -$1.52556.